Heather Shaw

5.8k total citations · 1 hit paper
43 papers, 3.6k citations indexed

About

Heather Shaw is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Heather Shaw has authored 43 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Heather Shaw's work include Cancer survivorship and care (7 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and HER2/EGFR in Cancer Research (5 papers). Heather Shaw is often cited by papers focused on Cancer survivorship and care (7 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and HER2/EGFR in Cancer Research (5 papers). Heather Shaw collaborates with scholars based in United States, United Kingdom and Spain. Heather Shaw's co-authors include Paul Bhar, Michael Hawkins, Neville Davidson, William J. Gradishar, Joyce O’Shaughnessy, Sergei Tjulandin, Neil Desai, David J. Kroll, Nicholas H. Oberlies and Johann S. de Bono and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Heather Shaw

41 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

2005 1.6k citations Heather Shaw et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heather Shaw United States	20	1.8k	1.1k	821	586	412	43	3.6k
Edgardo Rivera United States	36	2.7k 1.5×	914 0.9×	850 1.0×	491 0.8×	983 2.4×	63	4.5k
E O’Brien Ireland	30	863 0.5×	696 0.6×	724 0.9×	650 1.1×	353 0.9×	96	4.0k
Keun Seok Lee South Korea	39	2.8k 1.5×	736 0.7×	1.1k 1.3×	491 0.8×	1.3k 3.1×	175	4.9k
Ji Won Park South Korea	44	3.8k 2.1×	1.0k 0.9×	1.6k 1.9×	237 0.4×	410 1.0×	344	7.4k
Stefan Glück United States	40	3.2k 1.7×	1.2k 1.1×	1.1k 1.3×	132 0.2×	1.0k 2.5×	199	5.6k
Patrick J. Creaven United States	35	2.1k 1.1×	1.4k 1.3×	596 0.7×	166 0.3×	285 0.7×	127	3.9k
Yvonne G. Lin United States	42	2.0k 1.1×	2.3k 2.1×	523 0.6×	207 0.4×	1.1k 2.7×	86	5.3k
John F. Deeken United States	24	1.3k 0.7×	948 0.9×	502 0.6×	173 0.3×	266 0.6×	92	3.0k
Jae‐Hyun Park United States	40	1.3k 0.7×	2.2k 2.0×	703 0.9×	220 0.4×	535 1.3×	206	4.6k
Sohita Dhillon New Zealand	49	1.5k 0.8×	2.1k 2.0×	827 1.0×	83 0.1×	486 1.2×	156	6.5k

Countries citing papers authored by Heather Shaw

Since Specialization

Citations

This map shows the geographic impact of Heather Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Shaw more than expected).

Fields of papers citing papers by Heather Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Shaw. The network helps show where Heather Shaw may publish in the future.

Co-authorship network of co-authors of Heather Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Shaw. A scholar is included among the top collaborators of Heather Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Shaw. Heather Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boggan, Joel C., et al.. (2025). Health conditions seen frequently in hospitalized United States Veterans who served after 9/11/2001: A scoping review. Journal of Hospital Medicine. 20(7). 740–767.

Lee, Karla A., et al.. (2021). The gut microbiome: what the oncologist ought to know. British Journal of Cancer. 125(9). 1197–1209. 89 indexed citations

Wong, Yien Ning Sophia, Christopher C.T. Sng, Diego Ottaviani, et al.. (2021). Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital. Cancers. 13(23). 6085–6085. 2 indexed citations

Sng, Christopher C.T., Yien Ning Sophia Wong, Anjui Wu, et al.. (2020). Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience. Frontiers in Oncology. 10. 595804–595804. 17 indexed citations

Bonvin, Elise, Paola Falletta, Heather Shaw, Véronique Delmas, & Colin R. Goding. (2012). A Phosphatidylinositol 3-Kinase–Pax3 Axis Regulates Brn-2 Expression in Melanoma. Molecular and Cellular Biology. 32(22). 4674–4683. 35 indexed citations

Morra, Rosa, et al.. (2012). Concerted action of the PHD, chromo and motor domains regulates the human chromatin remodelling ATPase CHD4. FEBS Letters. 586(16). 2513–2521. 23 indexed citations

Yap, Timothy A., Laura Vidal, Jan Adam, et al.. (2010). Phase I Trial of the Irreversible EGFR and HER2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 28(25). 3965–3972. 295 indexed citations

Rumble, Meredith E., Francis J. Keefe, Jack D. Edinger, et al.. (2010). Contribution of Cancer Symptoms, Dysfunctional Sleep Related Thoughts, and Sleep Inhibitory Behaviors to the Insomnia Process in Breast Cancer Survivors: A Daily Process Analysis. SLEEP. 33(11). 1501–1509. 29 indexed citations

Perez, Alejandra, Banu Arun, Debu Tripathy, et al.. (2010). A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Research and Treatment. 120(1). 111–118. 75 indexed citations

10.

Wheeler, Jane L., James E. Herndon, April Coan, et al.. (2009). Use of tablet personal computers for sensitive patient-reported information.. PubMed. 7(3). 91–7. 46 indexed citations

11.

Abernethy, Amy P., James E. Herndon, Jane L. Wheeler, et al.. (2009). Feasibility and Acceptability to Patients of a Longitudinal System for Evaluating Cancer-Related Symptoms and Quality of Life: Pilot Study of an e/Tablet Data-Collection System in Academic Oncology. Journal of Pain and Symptom Management. 37(6). 1027–1038. 113 indexed citations

12.

Ranson, Malcolm, Heather Shaw, Jürgen Wolf, et al.. (2009). A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva®, OSI-774) in patients with advanced solid tumors of epithelial origin. Cancer Chemotherapy and Pharmacology. 66(1). 53–58. 30 indexed citations

13.

Abernethy, Amy P., James E. Herndon, Jane L. Wheeler, et al.. (2008). Improving Health Care Efficiency and Quality Using Tablet Personal Computers to Collect Research‐Quality, Patient‐Reported Data. Health Services Research. 43(6). 1975–1991. 117 indexed citations

14.

Payne, Judith K., et al.. (2008). Effect of Exercise on Biomarkers, Fatigue, Sleep Disturbances, and Depressive Symptoms in Older Women With Breast Cancer Receiving Hormonal Therapy. Oncology nursing forum. 35(4). 635–642. 183 indexed citations

15.

Anders, Carey K., P. Kelly Marcom, Bercedis L. Peterson, et al.. (2008). A Pilot Study of Predictive Markers of Chemotherapy-Related Amenorrhea Among Premenopausal Women with Early Stage Breast Cancer. Cancer Investigation. 26(3). 286–295. 96 indexed citations

16.

Olmos, David, R. Molife, Scott H. Okuno, et al.. (2007). Safety, tolerability and preliminary efficacy of the anti-IGF-IR monoclonal antibody CP-751,871 in patients with sarcomas and adrenocortical tumors.. Molecular Cancer Therapeutics. 6. 7 indexed citations

17.

Reid, Alison, Laura Vidal, Heather Shaw, & Johann S. de Bono. (2007). Dual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu). European Journal of Cancer. 43(3). 481–489. 126 indexed citations

18.

Carson, James W., Kimberly M. Carson, Laura S. Porter, et al.. (2007). Yoga for Women with Metastatic Breast Cancer: Results from a Pilot Study. Journal of Pain and Symptom Management. 33(3). 331–341. 133 indexed citations

19.

Ellis, Matthew J. & Heather Shaw. (2002). Letrozole in the treatment of breast cancer. Expert Opinion on Pharmacotherapy. 3(5). 607–617. 7 indexed citations

20.

Liu, Katharine, et al.. (1999). Effects of Chemotherapy and Tamoxifen on Cervical and Vaginal Smears in Bone Marrow Transplant Recipients. Acta Cytologica. 43(6). 1027–1033. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact